Biotech Communications in a Post-COVID World with Megan Prock McGrath

Megan Prock McGrath is the Managing Director at MacDougall, where she provides clients with corporate communications counsel to help them elevate their voices in the industry. She is passionate about healthcare solutions for today's pressing problems, particularly those designed to lower costs, improve care, and serve vulnerable populations. Here, Megan discusses the impact of the COVID-19 pandemic on the industry, shares insights on effective messaging for clinical trials, and addresses the healthcare issues faced by the LGBTQ+ community.Key Takeaways:- COVID-19 increased public awareness of drug development - Effective messaging for clinical trials- The LGBTQ+ community faces challenges in healthcare accessEpisode Timeline:1:50    The Impact of COVID-19 on biotech communication3:30    Is the public more informed about the world of biotech post-COVID?6:30    Effective messaging for clinical trials7:15    How to appeal to clinical trial participants11:20 The challenges of accessing Capital in a bear market14:15 Healthcare challenges in the LGBTQ+ community16:40 The controversy surrounding gender-diverse care20:10 The impact of AI on biotech communication21:45 AI and ethicsThis episode’s guest:Megan Prock McGrath on LinkedInMacDougall AdvisorsSubscribe and leave a 5-star review: https://pod.link/1496390646Contact Us!•            Join the conversation by leaving a comment!•            Follow us on Facebook, Twitter, Instagram, and LinkedIn!Thanks for listening! Hosted on Acast. See acast.com/privacy for more information.